J0576 – Injection, buprenorphine extended-release (brixadi), 1 mg

Long description

Injection, buprenorphine extended-release (brixadi), 1 mg

Short description

Inj buprenorph (brixadi) 1mg

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

Added

January 1, 2024

Last change

April 1, 2024 – No change

Termination date

March 31, 2024

Nearby J codes

• J0565 – Injection, bezlotoxumab, 10 mg
• J0567 – Injection, cerliponase alfa, 1 mg
• J0570 – Buprenorphine implant, 74.2 mg
• J0571 – Buprenorphine, oral, 1 mg
• J0572 – Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
• J0573 – Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
• J0574 – Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
• J0575 – Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
• J0577 – Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
• J0578 – Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
• J0582 – Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
• J0583 – Injection, bivalirudin, 1 mg
• J0584 – Injection, burosumab-twza 1 mg
• J0585 – Injection, onabotulinumtoxina, 1 unit
• J0586 – Injection, abobotulinumtoxina, 5 units
• J0587 – Injection, rimabotulinumtoxinb, 100 units